" /> Albinism, oculocutaneous, type ia - CISMeF





Preferred Label : Albinism, oculocutaneous, type ia;

Symbol : OCA1A;

CISMeF acronym : ATN; OCA1A; OCA1;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : OCA1; Oculocutaneous albinism, type I; Oculocutaneous albinism, tyrosinase-negative; Albinism I; ATN;

Description : Oculocutaneous albinism is a genetically heterogeneous congenital disorder characterized by decreased or absent pigmentation in the hair, skin, and eyes. The term 'albinism' includes specific ocular changes that are the results of reduced amounts of melanin in the developing eye; these abnormalities in the eye and optic system are specific and necessary for the diagnosis. Aside from decreased pigment in the iris and retina, optic changes include decreased visual acuity, misrouting of the optic nerves at the chiasm, and nystagmus (King et al., 2001). Although OCA caused by mutations in the TYR gene was classically known as 'tyrosinase-negative' OCA, Tripathi et al. (1992) noted that some patients with 'tyrosinase-positive' OCA may indeed have TYR mutations resulting in residual enzyme activity. These patients can be classified as having OCA1B. - Genetic Heterogeneity of Oculocutaneous Albinism OCA1, caused by mutations in the TYR gene, is divided clinically into 2 types: type IA, OCA1A, characterized by complete lack of tyrosinase activity due to production of an inactive enzyme, and type IB (OCA1B; 606952), characterized by reduced activity of tyrosinase. OCA2 (203200), OCA3 (203290), and OCA4 (606574) are somewhat milder forms of the disorder, caused by mutations in the OCA2 (611409), TYRP1 (115501), and;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the tyrosinase gene (TYR, 606933.0001);

Laboratory abnormalities : Absent tyrosinase activity;

Prefixed ID : #203100;

Details


You can consult :


Nous contacter.
24/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.